Regular Article
Autochthonous mouse models for prostate cancer: past, present and future

https://doi.org/10.1006/scbi.2001.0373Get rights and content

Abstract

Prostate cancer continues to be the second leading cancer related death among men. In order to more fully develop effective prevention and intervention strategies for this prevalent disease, the underlying molecular mechanisms of initiation, progression and metastatic spread must be understood. To this end mouse models have an essential role in prostate cancer research in that they can closely mimic the pathological and biochemical features of the disease. In this review we discuss the history of autochthonous murine models of prostate cancer, the essentials of the idealized mouse model for prostate cancer and speculate on approaches towards this goal.

References (140)

  • LQ Benson et al.

    Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2

    J Biol Chem

    (1999)
  • G Han et al.

    Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer

    J Biol Chem

    (2001)
  • JE McNeal

    Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread

    Hum Pathol

    (1992)
  • DF Gleason et al.

    Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

    J Urol

    (1974)
  • DF Gleason

    Histologic grading of prostate cancer: a perspective

    Hum Pathol

    (1992)
  • A Magklara et al.

    Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

    Urology

    (2000)
  • JI Miller et al.

    The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer

    J Urol

    (1992)
  • M Bettencourt et al.

    CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy

    J Urol

    (1998)
  • ER Sherwood et al.

    Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate

    J Urol

    (1990)
  • E Shapiro et al.

    Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis

    J Urol

    (1992)
  • TC Thompson et al.

    Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ

    Cell

    (1989)
  • RM Yang et al.

    Low p27 expression predicts poor disease-free survival in patients with prostate cancer

    J Urol

    (1998)
  • PH Smith

    Carcinoma of prostate: case against immediate hormonal therapy

    Prostate

    (1996)
  • D Bostwick et al.

    Prostatic intraepithelial neoplasia: animal models 2000

    Prostate

    (2000)
  • MS Lucia et al.

    Workgroup I: rodent models of prostate cancer

    Prostate

    (1998)
  • JE Green et al.

    Workgroup 3: transgenic and reconstitution models of prostate cancer

    Prostate

    (1998)
  • RD Klausner

    Studying cancer in the mouse

    Oncogene

    (1999)
  • C Abate-Shen et al.

    Molecular genetics of prostate cancer [in process citation]

    Genes Dev

    (2000)
  • P Sharma et al.

    Mouse models of prostate cancer

    Oncogene

    (1999)
  • N Greenberg et al.

    Prostate cancer in a transgenic mouse

    Proc Natl Acad Sci USA

    (1995)
  • SM Dilworth

    Cell alterations induced by the large T-antigens of SV40 and polyoma virus

    Semin Cancer Biol

    (1990)
  • J Gingrich et al.

    Metastatic prostate cancer in a transgenic mouse

    Cancer Res

    (1996)
  • J Gingrich et al.

    Pathologic progression of autochthonous prostate cancer in the TRAMP model

    Prostate Cancer and Prostatic Diseases

    (1999)
  • JR Gingrich et al.

    Androgen-independent prostate cancer progression in the TRAMP model

    Cancer Research

    (1997)
  • I Maroulakou et al.

    Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene

    Proc Natl Acad Sci USA

    (1994)
  • MA Shibata et al.

    Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations

    Cancer Res

    (1996)
  • S Kasper et al.

    Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer [corrected and republished article originally printed in Lab Invest 1998 Mar;78:319-333]

    Lab Invest

    (1998)
  • SS Harwig et al.

    Cryptdins: endogenous antibiotic peptides of small intestinal Paneth cells

    Adv Exp Med Biol

    (1995)
  • E Garabedian et al.

    A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells

    Proc Natl Acad Sci USA

    (1998)
  • C Perez-Stable et al.

    Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice

    Lab Invest

    (1996)
  • C Perez-Stable et al.

    Prostate cancer progression, metastasis, and gene expression in transgenic mice

    Cancer Research

    (1997)
  • R Barrios et al.

    RasT24 driven by a probasin promoter induces prostatic hyperplasia in transgenic mice

    Transgenics

    (1996)
  • X Zhang et al.

    Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein

    Prostate

    (2000)
  • L Stepanova et al.

    Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia

    Oncogene

    (2000)
  • S Kundu

    Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor

    Prostate

    (2000)
  • X Zhang et al.

    Abnormal prostate development in C3(1)-bcl-2 transgenic mice

    Prostate

    (1997)
  • E Bruckheimer et al.

    The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo

    Oncogene

    (2000)
  • J DiGiovanni et al.

    Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice

    Proc Natl Acad Sci USA

    (2000)
  • DK Trask et al.

    Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells

    Proc Natl Acad Sci USA

    (1990)
  • J- C Voelkel

    Genomic instability-based transgenic models of prostate cancer

    Carcinogenesis

    (2000)
  • Cited by (0)

    1

    Corresponding author. Email: [email protected]

    View full text